Literature DB >> 2522909

Modulation of chymase-mediated rat serosal mast cell degranulation by trypsin or diisopropyl fluorophosphate.

B Schick1, K F Austen.   

Abstract

Exposure of rat serosal mast cells (RSMC) to chymase, an endogenous secretory granule serine protease, at 37 degrees results in exocytosis, as determined by beta-hexosaminidase release. As the number of RSMC is increased with a set amount of chymase, the net percentage beta-hexosaminidase release decreases linearly, implying a finite set of cellular interactions per chymase unit. Pretreatment of RSMC with trypsin at 37 degrees renders them refractory to subsequent exocytosis mediated by chymase in a dose- and time-dependent fashion, with complete refractiveness occurring by 15 min at 37 degrees with 2.5 micrograms trypsin/ml. Anti-IgE-mediated coupled activation-secretion of RSMC is not affected by the same trypsin pretreatment. When RSMC are pretreated with trypsin (2.5 micrograms/ml) for 0-120 min at 1 degree a progressive loss of sensitivity to activation by chymase at 37 degrees occurs. RSMC susceptibility to chymase-mediated degranulation after trypsin pretreatment can be partially regenerated by culturing the RSMC for about 24 hr in medium at 37 degrees. These findings suggest that a trypsin-sensitive constituent, possibly a receptor or substrate, is necessary for the functional interaction of chymase with RSMC. When added with diisopropyl fluorophosphate (DFP), chymase does not induce RSMC degranulation at 37 degrees. However, if the DFP is removed before addition of chymase at 37 degrees or is added after the chymase-priming event occurs at 1 degree, subsequent degranulation at 37 degrees is not inhibited. Thus, the induction and not the secretion phase is DFP-inhibitable in chymase-induced activation-secretion. In addition, the priming but not the exocytosis phase of chymase-initiated RSMC activation-secretion, which is not dependent on temperature and calcium ion concentration, involves a cellular trypsin-sensitive protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522909      PMCID: PMC1385233     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  TRIGGERING ACTION OF PHOSPHATIDASE A AND CHYMOTRYPSINS ON DEGRANULATION OF RAT MESENTERY MAST CELLS.

Authors:  B UVNAES; J ANTONSSON
Journal:  Biochem Pharmacol       Date:  1963-08       Impact factor: 5.858

2.  A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

Authors:  B C HUMMEL
Journal:  Can J Biochem Physiol       Date:  1959-12

3.  Non-pancreatic proteases of the chymotrypsin family. I. A chymotrypsin-like protease from rat mast cells.

Authors:  J Kawiak; W H Vensel; J Komender; E A Barnard
Journal:  Biochim Biophys Acta       Date:  1971-04-14

Review 4.  Activation of mast cells for mediator release through IgE receptors.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1984

5.  Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.

Authors:  B Schick; K F Austen; L B Schwartz
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

6.  A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue.

Authors:  M Kaliner; K F Austen
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

7.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

8.  Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.

Authors:  B Schick; K F Austen
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

9.  Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.

Authors:  E L Becker; K F Austen
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

10.  An enzyme in mast cells with properties like chymotrypsin.

Authors:  E P BENDITT; M ARASE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  5 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.

Authors:  Tony L Yaksh; Kelly A Eddinger; Shinichi Kokubu; Zhenping Wang; Anna DiNardo; Roshni Ramachandran; Yuelian Zhu; Yajun He; Fieke Weren; Daphne Quang; Shelle A Malkmus; Katherine Lansu; Wesley K Kroeze; Brian Eliceiri; Joanne J Steinauer; Peter W Schiller; Peter Gmeiner; Linda M Page; Keith R Hildebrand
Journal:  Anesthesiology       Date:  2019-07       Impact factor: 7.892

3.  Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.

Authors:  B Schick
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  Botulinum toxin blocks mast cells and prevents rosacea like inflammation.

Authors:  Jae Eun Choi; Tyler Werbel; Zhenping Wang; Chia Chi Wu; Tony L Yaksh; Anna Di Nardo
Journal:  J Dermatol Sci       Date:  2018-12-28       Impact factor: 4.563

5.  Interaction of primary mast cells with Borrelia burgdorferi (sensu stricto): role in transmission and dissemination in C57BL/6 mice.

Authors:  Quentin Bernard; Zhenping Wang; Anna Di Nardo; Nathalie Boulanger
Journal:  Parasit Vectors       Date:  2017-06-27       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.